Resource Center

Sort by:


The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis

Niesel K, et al. EMBO Mol Med. 2021;13(e13412).


Microfluidic-based immunohistochemistry combined with next-generation sequencing on diagnostic tissue sections for detection of tumoral BRAF V600E mutation

Leblond L-A, et al. American Journal of Clinical Pathology. 2019;152(1): 59-73.


Ultra-fast and automated immunohistofluorescent multistaining using a microfluidic tissue processor

Cappi G, et al. Scientific Reports. 2019;9(4489).


Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections

Migliozzi D, et al. Microsystems & Nanoengineering. 2019;5(59).


Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study

Aimi F, et al. Virchows Arch. 2019;475: 313–323.


A microfluidic platform towards automated multiplexed in situ sequencing

Maïno N, et al. Scientific Reports. 2019;9(3542).


Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma

Brajkovic S, et al. Diagnostic Pathology. 2018;13(79).


Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections

Brajkovic S, et al. Laboratory Investigation. 2017;97: 983–991.


Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs

Ciftlik AT, et al. Proceedings of the National Academy of Sciences USA (PNAS). 2013;110(14): 5363-5368.

View more resources